TrialBMC infectious diseases2017

Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections.

Pranab K Mukherjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.